Twiddy-R-R-Dr near Vermette MB (106 Result(s))

We offer reliable and affordable painting in the Eastern Manitoba District. D & R Painting only uses quality paints, primers and stains on every job. Call us now for an estimate!

"

Structure Monitoring Technology Ltd. or SMT, designs software and electronics used to monitor and evaluate the integrity and performance of commercial and residential buildings. Real-time sensor analysis and remote data collection have allowed Engineers and Researchers to validate designs, materials and methods to produce more efficient & durable buildings, reducing their environmental impact while improving quality assurance throughout the construction and/or restoration process. Founded in 2006, SMT has expanded to include low & high value building projects throughout the world. SMT fosters award winning innovation and scientific excellence in both our product lines and services as well as in our commitment to customers, clients, & researchers.SMT has deployed systems across North America ranging from simple wood frame homes, to glass and steel skyscrapers, shopping centers, heritage buildings, art museums, data centers, and national research labs. The Building Intelligence platform addresses the need for automated remote data collection with analytics of building performance trends/events.

Turning Agri-Food ideas Into Healthy OpportunitiesOur VisionEstablish Manitoba as a nationally and internationally recognized centre of research, production, marketing, development and commercialization of agricultural products for health.Our MissionPromote and support the development of a strong functional food, food ingredient and natural health products research community and industry in Manitoba.World Class – Manitoba BasedManitoba Agriculture Investment – interiorBackgroundLocated in Winnipeg, Manitoba Canada in heart of the Canadian Prairies, MAHRN promotes Manitoba's capacity and capabilities for the testing and assessment of plant and animal-based bioactive compounds, from isolation and characterization through clinical proof of safety and efficacy to product development and commercialization.MAHRN supports the commercialization of these bioactives as functional foods, food ingredients and natural health products through project coordination, communications, outreach and test market services.

ContactEnhanced Accelerator ModelFounded in 1997 by renowned bio-entrepreneur Dr. Albert D. Friesen, the GVI team has extensive experience in technology development to offer its clients. The Company provides services to client companies through an enhanced accelerator model and active participation. GVI takes the idea of an incubator to the next level, becoming actively involved with each new venture and offering a tailored mix of services vital to successfully develop a technology that will address market opportunities.State of the ArtGVI believes that entrepreneurs on the leading edge of new and innovative technologies can benefit from a location that complies with the highest standards needed for the industry. To that end, GVI is situated in a newly constructed facility that houses both the GVI research and management staff, and several client companies. The custom designed building provides access to business structure and state of the art equipment.Building ValueA proven track record and an experienced and talented team make Genesys Venture Inc. a unique vehicle for developing innovative ventures.

Murray Chevrolet is a dealership in Winnipeg, MB, specializing in the sale of new and used Chevrolet vehicles, offering comprehensive services including financing, maintenance, and collision repair.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.